Cargando…
PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin
Programmed cell death 1 ligand 1 (PD-L1) is a ligand of programmed cell death 1 (PD-1) that functions as an immune checkpoint by down-regulating immune responses. To determine whether PD-L1 is a therapy target in vitiligo treatment, Pmel-1 vitiligo mice were treated with a PD-L1 fusion protein. Trea...
Autores principales: | Miao, Xiao, Xu, Rong, Fan, Bin, Chen, Jie, Li, Xin, Mao, Weiwei, Hua, Shengyuan, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785514/ https://www.ncbi.nlm.nih.gov/pubmed/29371688 http://dx.doi.org/10.1038/s41598-018-19407-w |
Ejemplares similares
-
CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015) -
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
por: Agarwal, Priti, et al.
Publicado: (2014) -
Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
por: Shimshek, Derya R., et al.
Publicado: (2016) -
Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011) -
Psychosocial and quality-of-life factors associated with depigmentation therapy for vitiligo
por: Cadmus, Simi D., et al.
Publicado: (2023)